Sarepta Therapeutics to Present Company Overview at the 2017 35th Annual J.P. Morgan Healthcare Conference
January 03 2017 - 8:30AM
Business Wire
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial
stage developer of innovative RNA-targeted therapeutics, today
announced that it is scheduled to present at the
35th Annual J.P. Morgan Healthcare
Conference in San Francisco, CA on Tuesday,
January 10, 2017 at 7:30 a.m. PST (10:30 a.m.
EST). Edward Kaye, Sarepta's chief executive officer, will be
the presenter.
The presentation will be webcast live on the investor relations
section of the Sarepta Therapeutics website
at www.sarepta.com and will be archived under the events
and presentations section following the presentation for 90 days.
Please connect to Sarepta's website several minutes prior to the
start of the broadcast to ensure adequate time for any software
download that may be necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage
biopharmaceutical company focused on the discovery and development
of unique RNA-targeted therapeutics for the treatment of rare
neuromuscular diseases. The Company is primarily focused on rapidly
advancing the development of its potentially disease-modifying DMD
drug candidates. For more information, please visit us
at www.sarepta.com.
Internet Posting of Information
We routinely post information that may be important to investors
in the 'For Investors' section of our web site
at www.sarepta.com. We encourage investors and potential
investors to consult our website regularly for important
information about us.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170103005439/en/
Sarepta Therapeutics, Inc.Media and Investors:Ian Estepan,
617-274-4052iestepan@sarepta.comorW2O GroupBrian Reid,
212-257-6725breid@w2ogroup.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Sep 2023 to Sep 2024